Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-030424
Filing Date
2018-12-07
Accepted
2018-12-07 17:39:25
Documents
2
Period of Report
2018-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5211
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4300
  Complete submission text file 0000899243-18-030424.txt   10984
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Issuer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FLAGSHIP PIONEERING, INC. 55 CAMBRIDGE PARKWAY, STE 800E CAMBRIDGE MA 02139
Business Address
Berenson Stephen (Reporting) CIK: 0001760671 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38753 | Film No.: 181224415